Chemoradiotherapy improves survival after pancreatic adenocarcinoma resection
the ONA take:
Chemoradiotherapy was independently associated with improved overall survival after the resection of pancreatic adenocarcinoma, particularly among patients with R1 resection and pN1 disease, according to results from a large national cohort study published online ahead of print in the journal Cancer.
For the study, researchers sought to compare the effectiveness of chemotherapy with chemoradiotherapy in patients with pT1-3N0-1M0 pancreatic adenocarcinoma after pancreatectomy. Researchers identified 6,165 patients from the National Cancer Data Base who were treated with chemotherapy with or without radiotherapy.
Results showed that chemoradiotherapy was associated with improved overall survival vs chemotherapy alone. Subgroup analyses demonstrated that chemoradiotherapy was significantly associated with improved overall survival among those with pT3 or pN1 disease and both R0 resection and R1 resection.
The findings suggest that a prospective randomized head-to-head trial comparing adjuvant chemotherapy with chemoradiotherapy are warranted to assess their efficacy in patients with pancreatic adenocarcinoma who have undergone pancreatectomy.
Chemoradiotherapy was independently associated with improved overall survival after the resection of pancreatic adenocarcinoma.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Pediatric Hepatocellular Carcinoma: Challenges and Solutions
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|